Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Risk factors for severity and relapse of pseudomembranous colitis in an elderly population.

Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F.

Colorectal Dis. 2007 Feb;9(2):173-7.

PMID:
17223943
2.

[Epidemiology of Clostridium difficile infection].

Szczesny A, Martirosian G.

Przegl Epidemiol. 2002;56(1):49-56. Review. Polish.

PMID:
12150067
3.

Pseudomembranous colitis in children.

Brook I.

J Gastroenterol Hepatol. 2005 Feb;20(2):182-6. Review.

PMID:
15683418
4.

Antibiotic-associated diarrhoea.

Coté GA, Buchman AL.

Expert Opin Drug Saf. 2006 May;5(3):361-72. Review.

PMID:
16610966
5.

[Clostridium-difficile-associated diarrhea].

Bujanda L, Cosme A.

Gastroenterol Hepatol. 2009 Jan;32(1):48-56. doi: 10.1016/j.gastrohep.2008.02.003. Epub 2008 Dec 31. Review. Spanish.

PMID:
19174100
6.

[Risk factor for antibiotic-associated diarrhea. A review of the literature].

McFarland LV.

Ann Med Interne (Paris). 1998 Sep;149(5):261-6. Review. French.

PMID:
9791558
7.

Clostridium difficile: changing epidemiology and new treatment options.

Kuijper EJ, van Dissel JT, Wilcox MH.

Curr Opin Infect Dis. 2007 Aug;20(4):376-83. Review.

PMID:
17609596
8.

The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Andréjak M, Schmit JL, Tondriaux A.

Drug Saf. 1991 Sep-Oct;6(5):339-49. Review.

PMID:
1930740
9.

Clinical review of the management of fulminant clostridium difficile infection.

Jaber MR, Olafsson S, Fung WL, Reeves ME.

Am J Gastroenterol. 2008 Dec;103(12):3195-203; quiz 3204. doi: 10.1111/j.1572-0241.2008.02198.x. Epub 2008 Oct 1. Review.

PMID:
18853982
10.

Established and potential risk factors for Clostridum difficile infection.

Vaishnavi C.

Indian J Med Microbiol. 2009 Oct-Dec;27(4):289-300. doi: 10.4103/0255-0857.55436. Review.

11.

Treatment strategies for C. difficile associated diarrhea.

Stepan C, Surawicz CM.

Acta Gastroenterol Latinoam. 2007 Sep;37(3):183-91. Review.

PMID:
17955730
13.

Treatment of clostridium difficile colitis in the critical care setting.

Musher DM, Aslam S.

Crit Care Clin. 2008 Apr;24(2):279-91, viii. doi: 10.1016/j.ccc.2007.12.006. Review.

PMID:
18361946
14.

Pseudomembranous (antibiotic-associated) colitis.

Saco LS, Herlihy KJ, Powell DW.

J Am Acad Dermatol. 1981 May;4(5):619-29. Review.

PMID:
7016935
15.

Clinical recognition and diagnosis of Clostridium difficile infection.

Bartlett JG, Gerding DN.

Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S12-8. doi: 10.1086/521863. Review.

PMID:
18177217
16.

[Pseudomembranous colitis: report of four cases].

Solana de Lope J, Aguilera E, Vinageras JI, Pérez Manauta J.

Rev Gastroenterol Mex. 1997 Apr-Jun;62(2):113-6. Review. Spanish.

PMID:
9471661
17.

Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.

Bauer MP, Goorhuis A, Koster T, Numan-Ruberg SC, Hagen EC, Debast SB, Kuijper EJ, van Dissel JT.

Neth J Med. 2008 May;66(5):207-11. Review.

18.

Treatment of Clostridium difficile-associated disease.

Leffler DA, Lamont JT.

Gastroenterology. 2009 May;136(6):1899-912. doi: 10.1053/j.gastro.2008.12.070. Epub 2009 May 7. Review.

PMID:
19457418
19.

Clostridium difficile-associated disease: update and focus on non-antibiotic strategies.

Thompson I.

Age Ageing. 2008 Jan;37(1):14-8. Epub 2007 Nov 22. Review.

PMID:
18033775
20.

Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.

Stepan C, Surawicz CM.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):295-305. doi: 10.1586/17474124.1.2.295. Review.

PMID:
19072422

Supplemental Content

Support Center